REG - Lloyds Banking Group - Publication of Suppl.Prospcts

Lloyds BankingAnnouncement

24/04/2024 12:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240424:nRSX8869La&default-theme=true

RNS Number : 8869L  Lloyds Banking Group PLC  24 April 2024

 

24 April 2024

Publication of Supplementary Prospectus

The following Supplementary Prospectus has been approved by the Financial
Conduct Authority and is available for viewing:

Supplementary Prospectus dated 24 April 2024 (the "Supplementary Prospectus")
relating to the £25,000,000,000 Euro Medium Term Note Programme of Lloyds
Banking Group plc.

The Supplementary Prospectus should be read and construed in conjunction with
the prospectus dated 22 March 2024 relating to the above-mentioned programme
(the "Prospectus").

To view the Supplementary Prospectus, please paste the following URL into the
address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/8869L_1-2024-4-24.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/8869L_1-2024-4-24.pdf)

The Supplementary Prospectus has been submitted to the National Storage
Mechanism and will shortly be available for inspection at:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

For further information, please contact:

Investor Relations:

Douglas Radcliffe

Group Investor Relations Director

Tel:                  +44 (0) 20 7356 1571

Email:              douglas.radcliffe@lloydsbanking.com

 

Pascale Dorey

Director, Debt Investor Relations, Senior Funding and Covered Bonds

Tel:                  +44 (0) 20 7354 7402

Email:              pascale.dorey@lloydsbanking.com

 

Group Corporate Affairs:

Matt Smith

Head of Media Relations

Tel:                  +44 (0) 7788 352 487

Email:              matt.smith@lloydsbanking.com

 

Lloyds Banking Group plc

Registered Office

The Mound

Edinburgh EH1 1YZ

 

 

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in this announcement and the
Supplementary Prospectus may be addressed to and/or targeted at persons who
are residents of particular countries (specified in the Prospectus) only and
is not intended for use and should not be relied upon by any person outside
these countries and/or to whom this announcement and the Supplementary
Prospectus are not addressed. Prior to relying on the information contained in
this announcement and the Supplementary Prospectus, you must ascertain from
the Prospectus whether or not you are one of the intended addressees of the
information contained in this announcement and the Supplementary Prospectus.

In particular, this announcement and the Supplementary Prospectus do not
constitute an offer or invitation to subscribe for, or purchase securities in
the United States or in any other jurisdiction where such an offer or
invitation would be unlawful. This announcement and the Supplementary
Prospectus are not for distribution in the United States. The securities
described herein have not been, and will not be, registered under the U.S.
Securities Act of 1933, as amended (the "Securities Act"), or under any
relevant securities laws of any state of the United States of America and are
subject to U.S. tax law requirements. Subject to certain exceptions, the
securities may not be offered or sold within the United States or to, or for
the account or benefit of, U.S. persons or to persons within the United States
of America, as such terms are defined in Regulation S under the Securities
Act. There will be no public offering of the securities in the United States.

Your right to access this service is conditional upon complying with the above
requirement.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  PSPEAFLLAAALEFA